1. Home
  2. NEO vs CRAI Comparison

NEO vs CRAI Comparison

Compare NEO & CRAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NEO
  • CRAI
  • Stock Information
  • Founded
  • NEO 2001
  • CRAI 1965
  • Country
  • NEO United States
  • CRAI United States
  • Employees
  • NEO N/A
  • CRAI N/A
  • Industry
  • NEO Precision Instruments
  • CRAI Other Consumer Services
  • Sector
  • NEO Health Care
  • CRAI Consumer Discretionary
  • Exchange
  • NEO Nasdaq
  • CRAI Nasdaq
  • Market Cap
  • NEO 1.2B
  • CRAI 1.4B
  • IPO Year
  • NEO 1999
  • CRAI 1998
  • Fundamental
  • Price
  • NEO $10.21
  • CRAI $181.26
  • Analyst Decision
  • NEO Buy
  • CRAI Buy
  • Analyst Count
  • NEO 10
  • CRAI 1
  • Target Price
  • NEO $12.56
  • CRAI $235.00
  • AVG Volume (30 Days)
  • NEO 5.6M
  • CRAI 94.0K
  • Earning Date
  • NEO 10-28-2025
  • CRAI 10-30-2025
  • Dividend Yield
  • NEO N/A
  • CRAI 1.10%
  • EPS Growth
  • NEO N/A
  • CRAI 44.21
  • EPS
  • NEO N/A
  • CRAI 8.27
  • Revenue
  • NEO $709,162,000.00
  • CRAI $712,913,000.00
  • Revenue This Year
  • NEO $10.40
  • CRAI $9.01
  • Revenue Next Year
  • NEO $10.11
  • CRAI $4.26
  • P/E Ratio
  • NEO N/A
  • CRAI $21.56
  • Revenue Growth
  • NEO 10.10
  • CRAI 9.28
  • 52 Week Low
  • NEO $4.72
  • CRAI $152.57
  • 52 Week High
  • NEO $19.12
  • CRAI $214.66
  • Technical
  • Relative Strength Index (RSI)
  • NEO 60.50
  • CRAI 40.83
  • Support Level
  • NEO $9.83
  • CRAI $176.14
  • Resistance Level
  • NEO $11.41
  • CRAI $189.63
  • Average True Range (ATR)
  • NEO 0.48
  • CRAI 3.76
  • MACD
  • NEO -0.05
  • CRAI 0.17
  • Stochastic Oscillator
  • NEO 48.03
  • CRAI 44.27

About NEO NeoGenomics Inc.

NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. It operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.

About CRAI CRA International Inc.

CRA International Inc is a U.S.-based advisory firm that provides economic, financial, and management consultancy services. The company advises clients on economic and financial issues relating to litigation and regulatory proceedings and helps businesses set important business strategies and solve performance-related issues. The company's clients include domestic and foreign companies, government agencies, public and private utilities, and national and international trade associations. CRA International generates majority of its revenue from the United States, while it also has its presence in United Kingdom and Other Countries.

Share on Social Networks: